HemoTypeSCTM Point-of-care Testing as a Screening Tool for Sickle Cell Disease among Newborns in Ilesa, Nigeria. Niger J Paediatr [Internet]. 2026 May 8 [cited 2026 Jun. 16];53(1):20-7. Available from: https://www.njpaediatrics.com/index.php/njp/article/view/1236